Lipid nanoparticulate drug delivery system for the treatment of hepatic fibrosis

    DOI Logo 10.17352/ahr.000028

    Published On: January 28, 2021 | Pages: 001 - 003

    Author(s): Swarupananda Mukherjee*, Ayon Dutta and Dipanjana Ash
    Background: Irreversible hepatic fibrosis, an excessive production and accumulation of extra cellular matrix by hepatic stellate cells in the liver, becomes a remarkable economic burden in global health care system.Low therapeutic efficacy and undesirable systemic effect of conventional therapies limit their clinical applications to targethepatic stellate cells. Meth ... CrossMark Publons Harvard Library HOLLIS Search IT Semantic Scholar Get Citation Base Search Scilit OAI-PMH ResearchGate Academic Microsoft GrowKudos
    Abstract View Full Article View


    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on AHR